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Persistent organochlorine pollutants (POPs) are ubiquitous, bioaccumulative compounds with potential endocrine-disrupting effects.
They cross the placental barrier thereby resulting in in utero exposure of the developing fetus. The objective of this study was to
investigate whether maternal serum concentrations of polychlorinated biphenyls (PCBs) and p,p 0-dichlorodiphenyldichloroethylene
(p,p 0-DDE) during pregnancy are associated with son’s semen quality and reproductive hormone levels. During 2008–2009, we recruited
176 male offspring from a Danish cohort of pregnant women who participated in a study in 1988–1989. Each provided semen and blood
samples that were analyzed for sperm concentration, total sperm count, motility, and morphology, and reproductive hormone levels,
respectively. The maternal blood samples were collected in pregnancy week 30 and were analyzed for the concentrations of six PCBs
(PCB-118, -138, -153, -156, -170, and -180) and p,p 0-DDE. The potential associations between in utero exposure to SPCBs (pmol/ml),
Sdioxin like-(DL) PCBs (PCB-118 and -156) (pmol/ml), and p,p 0-DDE and semen quality and reproductive hormone levels were
investigated using multiple regression. Maternal median (range) exposure levels of SPCB, SDL-PCB, and p,p 0-DDE were 10.0 (2.1–35.0)
pmol/ml, 0.8 (0.2–2.7) pmol/ml, and 8.0 (0.7–55.3) pmol/ml, respectively, reflecting typical background exposure levels in the late 1980s
in Denmark. Results suggested that in utero exposure to SPCB, SDL-PCB, and p,p 0-DDE was not statistically significantly associated
with semen quality measures or reproductive hormone levels. Thus, results based on maternal PCB and p,p 0-DDE concentrations
alone are not indicative of long-term consequences for male reproductive health; however, we cannot exclude that these POPs in
concert with other endocrine-modulating compounds may have adverse effects.
Reproduction (2014) 148 635–646Introduction
Persistent organochlorine pollutants (POPs) such as
polychlorinated biphenyls (PCBs) and organochlorine
pesticides such as dichlorodiphenyltrichloroethane
(DDT) are ubiquitous, organic pollutants that have
been widely used until they were banned in Western
countries in the late 1970s. Because of their lipophilic
structure, they accumulate in adipose tissue and
bioaccumulate in the food chain (Safe 1990, Cook
et al. 2011) and, therefore, humans are at present
mainly exposed to these POPs through diet, for exampleq 2014 The authors
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Online version via www.reproduction-online.orgthrough consumption of fatty fish, dairy products, and
meat (Gasull et al. 2011). The compounds are persistent
and have long half-lives in human tissue (Wolff et al.
2000, Seegal et al. 2011), and can be detected in
humans worldwide due to their wide distribution and
usage. Many PCB congeners have been shown to
display hormone-modulating activities, and the DDT-
degradation product p,p 0-dichlorodiphenyldichloroethy-
lene (p,p 0-DDE) is regarded a potent androgen receptor
antagonist (Kelce et al. 1995). Both groups of substances
readily cross the placental barrier (Saxena et al. 1981,This work is licensed under a Creative Commons
Attribution 3.0 Unported License.
Pregnant women in the cohort (1988–1989)
n=965
Girl offspring or not identified in CRS registry
n=466
Lost to follow-up due to emmigration, death,
illness, and declined contact
n=31
Sons identified in CRS-registry
n=499
Sons who recieved questionaire in 2008
n=468
Sons who declined all or further contact
n=115
Sons invited to participate in the physical
examination 2008–2009
n=353
Consented to participate in the physical
examination
n=176
Sons who declined participation or did not
respond
n=177
No available data on in utero exposure to
PCBs and p,p ′-DDE (n=7), azoospermia (n=1),
abuser of anabolic steroids (n=1), extreme
PCBs and p,p ′-DDE concentrations (n=1)
n=10
Study population
complete case
n=166
Figure 1 Flow chart for recruitment of participants.
636 A Vested and othersJacobson et al. 1984), resulting in in utero exposure of
the developing fetus. In addition, substantial postnatal
exposure results from breastfeeding, whereby accumu-
lated compounds are transferred from the mother to
the infant.
Low sperm concentration is associated with a longer
time to pregnancy and a sperm concentration of
40!106/ml is considered a threshold below which
fecundity declines (Bonde et al. 1998). A recent study
from an ongoing surveillance of semen quality in young
Danish men reporting for military draft (1996–2010)
has suggested that only around 23% of young Danish
men have an optimal sperm concentration of above
40!106/ml and more than 9% morphologically normal
spermatozoa (Jørgensen et al. 2012). Furthermore,
studies suggest that young Danish men, alongside
young men from Norway and Germany, may have
lower sperm concentrations than young men in other
European countries (Jørgensen et al. 2002, Punab et al.
2002, Richthoff et al. 2002, Paasch et al. 2008, Axelsson
et al. 2011, Fernandez et al. 2011). Together with indi-
cations of increasing incidences of testicular cancer
and congenital malformations such as cryptorchidism
and hypospadias, this has led to the hypothesis that
exposure to endocrine-modulating compounds during
fetal life could cause an imbalance in the fetal hormonal
environment and affect normal development of male
reproductive organs, thereby causing long-term effects
on male reproductive health (Toppari et al. 1996,
Toppari & Skakkebaek 1998, Skakkebaek et al. 2001,
Sharpe et al. 2003).
Cross-sectional studies have indicated an inverse
association between serum levels of PCB153, PCB138,
and p,p 0-DDE exposure in adult life and sperm motility
(Rozati et al. 2002, Hauser et al. 2003, Richthoff et al.
2003, Toft et al. 2006), and studies of men living in areas
sprayed with DDT have suggested inverse associations
between p,p 0-DDE and sperm motility, semen volume,
total sperm count, and positive associations with sperm
tail defects and poor sperm chromatin condensation
(De Jager et al. 2006, Aneck-Hahn et al. 2007).
In addition, the Yu Cheng oil-disease provided insights
into the consequences of in utero exposure to high levels
of PCBs. These included increased abnormal sperm
morphology, decreased sperm motility, and reduced
oocyte penetration capacity among in utero exposed
cases (Guo et al. 2000).
Based on the hypotheses that fetal life exposures may
affect male reproductive organ development and cause
long-term effects on reproductive health, the aim of
this study was to conduct a population-based follow-up
study to investigate the potential effects of in utero
exposure to background levels of PCBs and p,p 0-DDE
on semen quality and reproductive hormone levels
among young postpubertal Danish men born in the
years 1988–1989. To our knowledge, this is the first
population-based follow-up study to address theReproduction (2014) 148 635–646associations between in utero exposure to PCBs and
p,p 0-DDE and semen quality and reproductive hormone
levels in early adult life.Materials and methods
Population
A Danish population-based pregnancy cohort was recruited in
1988–1989, when the pregnant women attended a routinely
scheduled consultation with a midwife in Aarhus, Denmark,
at pregnancy week 30. They answered a detailed question-
naire, were interviewed on dietary and lifestyle habits, and
provided a blood sample for storage in a biobank. Of all 1212
pregnant women invited, 965 (80%) participated (Olsen et al.
1995a, 1995b).
The follow-up for the male offspring of this cohort was
initiated in 2008, where the sons were invited to fill in an
internet-based questionnaire on health and lifestyle habits. In
2008–2009, the sons were invited to participate in a physical
examination at Aarhus University Hospital, Denmark, where
they provided a semen sample, a blood sample, and self-
estimated testicular volume using an orchidometer. One
hundred and seventy-six sons attended the physical exami-
nation, corresponding to a participation rate of 38% of all male
offspring in the source cohort (Fig. 1). All participants signed
a written informed consent before participation, and the study
was approved by the regional ethics committee (registration
number M-20010157).
Two participants were excluded from all statistical analyses
due to azoospermia and abuse of anabolic steroids respect-
ively. In addition, one participant was excluded due to an
extremely high maternal serum level of PCBs and p,p 0-DDE
(PCB-153 concentration: 12 ng/ml and p,p 0-DDE concen-
tration: 32 ng/ml) compared with the remaining participants,
leaving a study population of 173 available for this study.Data collection
The participants attended the physical examinations from
February 2008 until September 2009. The young men were
instructed to collect semen samples into plastic containers bywww.reproduction-online.org
In utero POP exposure and male reproduction 637masturbation, at their residence or at the hospital, and to keep
the samples close to the body during transport. At the hospital,
semen samples were stored in a heating chamber (37 8C) until
semen analysis. All participants reported time and date of
the semen sample collection and information on potential
spillage during semen sample collection. The participants were
instructed to self-measure their testicular volumes by using a
Prader orchidometer and finding the volume on the orchido-
meter, that best corresponded to the size of the testicle, going
from the smallest towards the largest volume on the
orchidometer. This method has previously been reported to
be a valid method for measurement of testicular size
(Ramlau-Hansen et al. 2007b). In addition, height and weight
were measured for each participant by an examiner.
The blood samples were taken between 0730 and 1330 h.
The participants were instructed to present at the physical
examination being in a fasted state for 10 h.Semen analysis
The semen analysis was initiated within 1 h from ejaculation
for 86% of the participants and all semen samples were
analyzed within 2 h from ejaculation. Conventional semen
analysis was performed according to World Health Organiz-
ation (WHO) guidelines from 1999 (World Health Organiz-
ation 1999) and the Nordic Association for Andrology Manual
on Basic Semen Analysis. The sperm concentration was
assessed on two dilutions of the semen sample using a
Neubauer counting chamber and the final sperm concentration
calculated from the sum of the two counts divided by a factor
derived from the dilution factor and the number of Neubauer
counting chamber squares counted. Sperm motility was
assessed in an aliquot of 6 ml semen by classifying spermatozoa
into four motility categories by counting the proportion of
rapidly progressive (O25 mm/s), slowlyprogressive (5–25 mm/s),
non-progressive (!5 mm/s), and immotile spermatozoa for
2!100 spermatozoa. This was repeated in a new aliquot of
6 ml semen and, hence, a total of 400 spermatozoa were
classified per semen sample. Additional information is shown
in the study reported by Vested et al. (2011). Furthermore,
sperm concentration and motility were assessed by computer-
assisted semen analysis (CASA), using the Copenhagen
Rigshospitalet Image House Sperm Motility Analysis System
(CRISMAS) Clinical software version 4.6 (Image House
Medical, IHMedical A/S, Copenhagen, Denmark), as pre-
viously described (Vested et al. 2011). For both conventional
and CASA motility assessment, participants with missing
information on motility assessments were assigned a mean of
each of the motility categories based on the participants with
information on sperm motility. The laboratory attended the
Special Interest Group in Andrology ESHRE Subcommittee
External Quality Assurance control program, and all tests
were within the central 50% of the reference results. The
sperm morphology was assessed using ‘Strict criteria’
(Menkveld et al. 1990). The assessments of morphology
were only included in the statistical analyses for the
participants where quality control status of the sperm
morphology smears were in agreement with the ‘strict
criteria’.www.reproduction-online.orgBlood sample analyses
The maternal serum samples were collected in pregnancy week
30 in 1988–1989 and stored atK20 8C until analysis in 2011.
The concentrations of p,p 0-DDE and six prevalent PCB
congeners (PCB-118, -138, -153, -156, -170, and -180) were
measured from 200 ml aliquots of maternal serum by liquid–
liquid extraction followed by gas chromatography coupled
with high resolution mass spectometry at the National Institute
for Health and Welfare (THL), Department of Environmental
Health, Kuopio, in Finland according to a sample pretreatment
method described by Koponen et al. (2013). Two blanks and
two control samples (NIST SRM 1589a) were included in each
batch of samples (nZ25) in order to control for laboratory
contamination and accuracy, and precision of the method
respectively. The average recoveries of measured POPs in the
control samples were 97–106% of the certified values. The
between-assay coefficient of variation (CV) was 4.0% (at
0.17 ng/ml) for PCB-118; 4.2% (at 0.54 ng/ml) for PCB-138;
2.7% (at 0.97 ng/ml) for PCB-153; 6.5% (at 0.08 ng/ml) for
PCB-156; 6.7% (at 0.21 ng/ml) for PCB-170; 2.6% (at 0.53 ng/ml)
for PCB-180; and 2.1% (at 11.2 ng/ml) for p,p 0-DDE. The
limits of quantification (LOQs) were between 2 and 5 pg/ml.
The concentrations of the six PCB congeners and p,p 0-DDE
were above LOQ in all samples.
In offspring blood samples, serum concentrations of LH,
FSH, estradiol, and testosterone were analyzed using immuno-
assays (cobas 6000 e601, Roche Diagnostics) at the
Department of Clinical Biochemistry, Aarhus University
Hospital, Denmark with CVs being 1.1–2.4, 1.9–2.1, 1.5–2.9,
and 2.2–4.5%, respectively, and concentrations of sex
hormone-binding globulin (SHBG) were measured using a
solid-phase two-site chemiluminescent immunometric assay
(IMMULITE 2000, Siemens Healthcare Diagnostics Products
Ltd., Gwynedd, UK) with a CV of 4.5–4.7%. Inhibin-B was
measured undiluted using a commercially available ELISA
(Oxford Bio-innovation Ltd, Oxfordshire, England, UK) with a
detection of 20 pg/ml and a CV below 7% at the Laboratory of
Reproductive Biology, Juliane Marie Centre for Women,
Children and Reproduction, University Hospital of Copen-
hagen, Denmark. The measurements below the detection limit
for estradiol (nZ3) were recoded to half the detection limit
(0.025 nmol/l).Statistical analysis
We converted each of the measured PCB congeners into molar
concentrations by dividing PCBs in pg/ml by the congener’s
molecular weight (g/mol), and PCB congeners were summed in
two exposure groupings: i) S all measured PCBs (pmol/ml)
(SPCBs), and ii) S dioxin-like PCBs (PCB-118 and PCB-156)
(SDL-PCBs) (pmol/ml). In addition, p,p 0-DDE concentration
in maternal blood samples was selected as a biomarker of
organochlorine pesticide exposure and converted into
molar concentration (pmol/ml). Each exposure variable was
divided into three exposure groups (low, medium, and high)
based on exposure tertiles. The outcome variables included
semen parameters (sperm concentration, total sperm count,
semen volume, percentage of progressive spermatozoa (rapidlyReproduction (2014) 148 635–646
Table 1 Maternal serum levels of six PCB congeners and p,p 0-DDE.
Median (range)
Wet weight serum concentrations (ng/ml)
PCB-118 0.17 (0.05–0.59)
PCB-138 0.75 (0.14–2.58)
PCB-153 1.46 (0.27–5.81)
PCB-156 0.10 (0.02–0.34)
PCB-170 0.38 (0.08–1.14)
PCB-180 0.71 (0.15–2.44)
p,p 0-DDE 2.55 (0.23–17.59)
Lipid-adjusted serum concentrations (ng/g lipid)
638 A Vested and othersprogressive and slowly progressive), percentage of motile
spermatozoa (rapidly progressive, slowly progressive, and
non-progressive spermatozoa), and percentage of morpho-
logically normal spermatozoa, mean right and left testi-
cular volume, and reproductive hormones (testosterone, free
testosterone calculated as suggested by Vermeulen et al.
(1999), estradiol, LH, FSH, SHBG, and inhibin B).
The crude differences between tertile exposure groups and
linear trends on continuous SPCBs, SDL-PCBs, and p,p 0-DDE
concentrations and the studied outcomes (untransformed) were
assessed by linear regression analysis with robust variance
estimates. The adjusted trends were tested by multiple
regression analysis, by entering the summed PCB levels or
p,p 0-DDE levels as continuous variables.
The outcome variables were natural logarithm (ln) transformed
before multiple regression analysis, and low PCB groups or low
p,p0-DDE group were used as referents. The results from the
multiple regression analyses are presented as relative differences
on the original measurement scale with 95% confidence intervals
(95% CI). All multiple regression results were adjusted for the
history of reproductive tract disease (inguinal hernia, varicocele,
testicular hydrocele, incarcerated hernia, phimosis, torsio testis,
clamydia, gonorrhea, and epididymitis combined into a
combined into one variable, yes/ no), sons’ BMI, (kg/m2)
(Sermondade et al. 2013), sons’ smoking status (current and
occasional smoker/ ex and never smoker) (Ramlau-Hansen et al.
2007c), maternal smoking during pregnancy (yes/ no) (Ramlau-
Hansen et al. 2007a), socioeconomic status (total annual income
for the household in 1987 (!200 000 DKK/R200 000 DKK)),
andmaternal serum total lipidconcentration (continuously ing/l).
Total lipid concentration in maternal serum (g/l) was calculated
using the following equation for estimation of total lipid based on
the information on serum cholesterol and triglycerides: total
lipidZ0.96C1.28!(cholesterol (g/l)Ctriglycerides (g/l)). For
this calculation, the average molecular weights of cholesterol
and triglycerides were assumed to be 571 and 807 g/mol,
respectively, based on the assumption that the proportion of
free and esterified cholesterol was 1:2 (Rylander et al. 2006).
In addition, results on sperm concentration, total sperm count,
percentage progressive spermatozoa, percentage motile sperma-
tozoa, semen volume, and testicular volume were adjusted for
abstinence time (%48 h/R49 h); sperm concentration was
adjusted for spillage during semen sample collection (yes/ no);
percentage of progressive spermatozoa and percentage of motile
spermatozoa were adjusted for time from ejaculation to semen
analysis (continuous, minutes); and the reproductive hormones
were adjusted for time of the day of blood sampling
(0730–0929 h/0930–1129 h/R1130 h). The participants who
reported spillage during semen sample collection were excluded
from multiple regression analysis on total sperm count and
semen volume. All statistical analyses were performed using Stata
12.1 software (Stata Corporation, College Station, TX, USA).PCB-118 20 (6–60)
PCB-138 88 (16–263)
PCB-153 165 (31–591)
PCB-156 12 (2–37)
PCB-179 43 (9–148)
PCB-180 81 (18–277)
p,p 0-DDE 288 (31–2208)Multiple imputation analyses
Multiple imputation was used to handle missing data under the
assumption that data fulfilled the missing at random criteria
(Sterne et al. 2009).Reproduction (2014) 148 635–646The data on the exposure variables were missing on seven
participants due to missing maternal blood samples or
inadequate blood sample volume for POP concentration
measurements. The numbers of participants with missing data
in the outcome variables ranged between two and eight and the
number of participants with missing values in the co-variates
ranged between 0 and 15.
For the main imputation model, 100 datasets were imputed
with values for missing data. Before imputation, assumptions of
normal distributions of the residuals of all continuous variables
imputed on the linear scale in the multiple imputation model
were checked and confirmed. We used the best transformations
of the outcome variables for the multiple imputation of missing
values (sperm concentration: cubic root; total sperm count,
semen volume, and inhibin B: square root; progressive motility
and all motility: squared; FSH: ln; and morphologically normal
spermatozoa, LH, estradiol, testosterone, free testosterone, and
SHBG; no transformation). Imputations for the main model
were based on including all outcomes, exposure variables,
and potential confounders mentioned above plus fever within
the last three months (participants), maternal pre-pregnancy
BMI, parity, maternal alcohol consumption-, maternal edu-
cational level, and maternal serum hexachlorbenzene level
during pregnancy in the predictive models. In addition, interval
censoring was allowed for variables that were imputed on
a continuous scale according to plausible ranges predicted
from the ranges within the dataset and limits of detection.
All imputations and corresponding analyses were performed
using Stata 12.1.
Sensitivity analyses with different imputation models were
performed to check for consistency in results under different
imputation models, but no discernible differences were
observed in results (details available upon request).Results
The 173 male offspring participating in the follow-up
study had a median (range) age of 20 (19–21) years.
Complete case data on maternal pregnancy week 30
serum concentrations (ng/ml) and lipid-adjusted serum
concentrations (ng/g lipid) of p,p 0-DDE, and thewww.reproduction-online.org
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Reproduction (2014) 148 635–646measured PCB congeners (PCB-118, -138, -153, -156,
-170, and -180) are given in Table 1, and characteristics
of the participants according to tertiles of SPCB and
p,p 0-DDE exposure are shown in Table 2. Maternal
serum lipid concentrations and sons’ abstinence time
differed substantially among the exposure groups. The
mothers in the lowest SPCB tertile had statistically
significantly lower serum lipid levels than mothers in
the highest tertile, and more participants in the lowest
SPCB- and p,p 0-DDE tertiles had been sexually abstinent
for more than 2 days compared with the highSPCB tertile
and both medium and high p,p 0-DDE tertiles (Table 2).
The results from the main multiple imputation model
showed no consistent associations between any of the
exposure variables (SPCB, SDL-PCB, or p,p 0-DDE) and
the studied outcomes for either crude or adjusted data
(Tables 3, 4, and 5). However, in crude models, there
were statistically significantly lower testosterone, free
testosterone, estradiol, and LH levels in the medium
SPCB exposure group compared with the reference
group (low), which were corroborated by the adjusted
analyses, although not statistically significant for LH
(Table 3). In addition, sons in the medium p,p 0-DDE
exposure tertile had significantly lower semen volume
and percentage of progressive spermatozoa compared
with the reference group, but differences between the
reference group and the sons exposed to the highest
p,p 0-DDE tertile were not statistically significant. After
adjustment, differences between the reference groups
and the medium exposure groups attenuated and were
no longer statistically significant. However, in the crude
analyses, both the medium and the high tertile had
significantly less percentage motile spermatozoa
compared with the low p,p 0-DDE tertile. This was
corroborated by the adjusted analyses with a significant
difference between the high and the low tertiles and a
tendency toward less spermatozoa in the medium
tertile compared with the reference. None of the
differences between groups were, however, corrobo-
rated by statistically significant trends on continuous
exposures (Table 5).
There were no indications of threshold effects or dose–
response relationships between in utero exposure to
SPCB, SDL-PCB, and p,p 0-DDE and semen quality
measures or reproductive hormone levels at the
examined exposure ranges.
CASA results supported the results from the conven-
tional semen analysis assessment (Supplementary
Tables 1, 2 and 3, see section on supplementary data
given at the end of this article). In addition, complete case
analyses (Supplementary Tables 4, 5 and 6) and sensitivity
analyses with different imputation models (fewer pre-
dictors, more predictors, and a model where the best
transformation of outcomes and variables were used in
stead of ln-transformations in the multiple regression
model) all supported the results from the main imputation
model, except that the ‘best transformation’ modelwww.reproduction-online.org
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In utero POP exposure and male reproduction 641
www.reproduction-online.orgindicated a positive association between continuous p,p 0-
DDE exposure and sperm concentration (Supplementary
Table 7), which was even more pronounced in the
complete case analyses (Supplementary Table 6). In
addition, complete case analyses also suggested that
higher in utero exposure to p,p 0-DDE was statistically,
significantly associated with higher total sperm count in
adult life (Supplementary Table 6).
When comparing PCB and p,p 0-DDE levels, according
to level of participation in the study, there were no
statistically significant differences in exposure levels
between the sons who participated in the physical
examination, those who only filled in questionnaires,
and those who were lost to follow-up (PZ0.11, PZ0.12,
and PZ0.48 for SPCB, SDL-PCB, and p,p 0-DDE,
respectively; Table 6). Furthermore, there were no
differences in maternal pre-pregnancy BMI, parity, social
class, serum total lipid level, alcohol consumption
during pregnancy or sons’ BMI, or smoking status.
There was a tendency toward a higher degree of young
men who had a history of reproductive tract disease
among those who participated in the physical exami-
nation compared with those who only filled in the
questionnaire (PZ0.06). The mothers of sons who did
not participate in follow-up were statistically signi-
ficantly younger than mothers of sons who participated
in the physical examination. In addition, we identified
less reported smoking during pregnancy among the
mothers whose sons participated in the physical
examination compared with those who did not partici-
pate in follow-up (Table 6).Discussion
In this study, we found that semen quality measures and
reproductive hormone levels were not consistently,
adversely related to in utero exposure to either SPCBs,
SDL-PCBs, or p,p 0-DDE when using the approach of
analysing one chemical/one chemical group at a time.
A study on mice exposed in utero and postnatally
through lactation to a mixture of PCB-101 and PCB-118
to doses estimated to represent 0, 1, 10, and 100 mg
PCB/kg per day suggested that perinatal PCB exposure
was associated with decreased testis weight and sperm
viability but not with sperm concentration. At the highest
PCB dose, a significant reduction in anogenital distance
(AGD) was also observed compared with controls (Pocar
et al. 2012). Another study, in which rat dams were
treated with a single dose of 375 mg PCB-118/kg on
gestational day 6 found that in utero exposure to PCB-
118 was associated with increased AGD and reduced
testis and epididymis weights in the male offspring. In
addition, sperm concentration, daily sperm production,
and sperm counts were significantly reduced compared
with unexposed controls. In this study, exposure levels
were w100-fold higher than human exposure levels in
breast milk (Kuriyama & Chahoud 2004).Reproduction (2014) 148 635–646
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Table 6 Characteristics of mothers and sons at baseline (pregnancy week 30) and follow-up according to the level of participation.
Characteristics
Participating in physical
examination, nZ176
Filling in questionaire
only, nZ157
Not in follow-up,
nZ143 P value
Maternal
SPCBs (pmol/ml), median (p25–p75) 10.1 (7.3–12.9) 10.4 (7.6–13.0) 9.0 (6.6–12.2) 0.12a
SDioxin-like-PCBs (pmol/ml), median (p25–p75) 0.8 (0.6–1.1) 0.8 (0.6–1.1) 0.8 (0.6–1.0) 0.11a
p,p 0-DDE (pmol/ml), median (p25–p75) 8.2 (5.2–12.4) 7.3 (4.9–11.2) 8.0 (5.1–11.9) 0.48a
Maternal age (years), mean (S.D.) 29.6 (4.4) 29.0 (4.2) 28.3 (4.5) 0.03b
Prepregnancy BMI (kg/m2), median (p25–p75) 21.0 (19.8–22.3) 20.7 (19.5–22.7) 21.2 (19.1–23.1) 0.77a
Nulliparous, n (%) 112 (64) 96 (61) 83 (58) 0.60c
Smoking during pregnancy, n (%) 55 (33) 53 (37) 63 (47) 0.03c
High social class, n (%) 96 (60) 87 (64) 77 (61) 0.78c
Blood total lipid level (g/l), median (p25–p75) 8.6 (7.7–9.6) 8.8 (7.9–10.0) 8.7 (7.9–9.6) 0.33a
Alcohol during pregnancy (g/day), median (p25–p75) 2.0 (0.4–4.6) 1.5 (0–4.4) 1.5 (0–3.5) 0.53a
Male offspring follow-up
BMI (kg/m2), median (p25–p75)d 22.2 (20.5–24.1) 22.4 (20.7–24.4) – 0.50e
Current/occasional smoker, n (%) 83 (50) 66 (43) – 0.24c
History of reproductive tract disease, n (%) 23 (14) 11 (7) – 0.06c
aKruskal–Wallis test. bOne-way ANOVA test. cc2-test. dBMI is calculated from anthropometric measures based on self-reported values. eWilcoxon
rank-sum test.
In utero POP exposure and male reproduction 643We did not find any inverse associations between
maternal pregnancy week 30 serum levels of PCB or
p,p 0-DDE and testis size or sperm count. This supports
previous epidemiological studies on associations
between in utero exposure and male reproductive
organ development, which generally found weak or
no effects. Two nested case–control studies found that
maternal pregnancy levels of p,p 0-DDE were not
statistically significantly associated with increased risk
of hypospadias and cryptorchidism (Longnecker et al.
2002, Bhatia et al. 2005), and two nested case-control
studies on placental- and maternal serum concentrations
of PCB during pregnancy found no increased risk of
cryptorchidism (McGlynn et al. 2009, Virtanen et al.
2012). However, indications of increased risks of
hypospadias and cryptorchidism in relation with
in utero exposure to PCB and p,p 0-DDE have also been
reported (Brucker-Davis et al. 2008, McGlynn et al.
2009, Rignell-Hydbom et al. 2012). We cannot exclude
that the lack of statistically significant associations in the
current study might be due to a lack of exposure contrast
in the data. However, median maternal serum POP
levels in our study were comparable with those of
Rignell-Hydbom et al. (2012), who found a tendency
toward an association with p,p 0-DDE levels. The data
collection period in the Rignell–Hydbom study spans
from 1986 until 2002, while maternal POP levels during
pregnancy in the studies by Longnecker et al. (2002),
Bhatia et al. (2005), and McGlynn et al. (2009) were
substantially higher than the present concentrations,
corresponding to a heavier POP load during the 1960s
when specimens for these studies were collected.
The study by Guo et al. (2000) on young males
prenatally exposed to high levels of PCBs and poly-
chlorinated dibenzofurans (PCDFs) as a result of the Yu
Cheng oil-disease suggested long-term adverse effects
on sperm quality in terms of abnormal morphology,www.reproduction-online.orgdecreased sperm motility, and reduced oocyte
penetration capacity (Guo et al. 2000).
We did not find any consistent associations between
in utero exposure to PCBs or p,p 0-DDE and sperm
morphology or sperm motility in the present study,
except from the statistically significant less percentage
motile spermatozoa in the high p,p 0-DDE tertile
compared with the reference tertile, which was not
corroborated by a significant trend on the continuous
exposure. The males born to exposed Yu Cheng women
were exposed to high levels of PCBs and PCDFs during
fetal development because of their mothers’ accidental
ingestion of cooking oil contaminated with these POPs.
As the young men in our cohort were only exposed
to background POP levels in the late 1980s, differences
between the findings of the Guo et al. (2000) study and
our study are likely to be explained by differences in
exposures levels.
Another study investigated the possible male repro-
ductive health consequences of perinatal exposure to
dioxins in a cohort of men born to mothers who were
exposed to dioxins as a result of the trichlorophenol
plant explosion near Seveso, Italy in 1976. This study
found that sons who were exposed both in utero and
through breast feeding had significantly lower sperm
concentration, total sperm count, progressive motility,
and total motile count than the unexposed controls.
There were no differences in semen quality measures
between sons, who were only exposed in utero, and
controls (Mocarelli et al. 2011). In our study, we
observed no associations between the dioxin-like PCBs
(PCB-118 and PCB-156) and any of the investigated male
reproductive health outcomes. This could be due to
differences in exposure levels between the two studies
or to a higher contribution by postnatal exposure, which
was not assessed in the present study.
During the last decade, more focus has been turned
toward “the mixture effect” – that compounds withReproduction (2014) 148 635–646
644 A Vested and otherspotential hormone-modulating effects may only contri-
bute with minor effects at the individual compound
level, and that a health effect may only appear in concert
with other chemicals. Animal studies have suggested that
exposure to a mixture of different compounds can
produce effects on male reproductive health at concen-
trations where there are no associations between the
individual compounds and the male reproductive health
outcome (Christiansen et al. 2008, Kortenkamp 2008),
and studies have indicated that the mixture of
compounds rather than individual chemical exposures
may contribute to effects on male reproductive health
(Krysiak-Baltyn et al. 2012). With the mixture effect in
mind, we cannot exclude that PCB and p,p 0-DDE
exposure in concert with other potential hormone-
modulating compounds may result in adverse associ-
ations with male reproductive health, although overall
no statistically consistent significant results were found
in the current study using the single chemical/chemical
group approach.
Complete case results and the multiple regression
analyses, in which we checked ln-transformed results
with a model using the most optimal transformations of
the outcome variables, suggested a positive association
between maternal serum levels of p,p 0-DDE during
pregnancy and the sperm concentration of sons in
adult life. Similar findings have been reported indepen-
dently in subsets of the study populations of two studies
assessing the effects of adult male serum levels of p,p 0-
DDE on male reproductive health (Toft et al. 2006,
Haugen et al. 2011). Due to the antiandrogenic proper-
ties of p,p 0-DDE, this was opposite of what we expected
and may be a result of multiple testing.
A previous study on this cohort of young men found
inverse associations between maternal pregnancy week
30 serum levels of perfluorooctanoic acid (PFOA) and
sperm concentration and total sperm count and positive
associations to LH and FSH (Vested et al. 2013). A sub-
analysis adjusting for continuous PFOA did not alter the
directions or significance levels of the results for either
SPCB, SDL-PCB, or p,p 0-DDE analyses (data not shown).
This study is to our knowledge the first population-based
follow-up study to report on associations between in utero
exposure to PCBs and p,p0-DDE and semen quality and
reproductive hormone levels in early adult life.
The longitudinal design of the present study has a
major strength compared to cross-sectional studies
attempting to study the same hypothesis. It allowed us
to estimate the effects of exposure to POPs during a
proposed critical window of exposure to exogenous
compounds with semen quality measures and reproduc-
tive hormone levels later in life.
A possible limitation of this study includes the risk of
selection bias, which could be present if study
participation was associated with both POP exposure
and reproductive outcomes. It has been shown by former
studies that men experiencing fertility problems are moreReproduction (2014) 148 635–646willing to participate in studies investigating male
reproductive health outcomes (Bonde et al. 1996). The
participants in this cohort were young and for the most
part had no reproductive experience. Thus, it is unlikely
that participation in this study was related to fecundity.
However, there was a tendency toward more partici-
pants having a history of reproductive tract disease
among the participants who attended the physical
examination compared with the young men who only
filled in the internet based questionnaire (PZ0.06).
However, there is no reason to believe that a potential
oversampling of young men with a history of reproduc-
tive tract disease would be related to exposure and thus
unlikely that this would have biased the results.
Participation rate of the physical examination was
38%. However, losses to follow-up were not associated
with SPCB, SDL-PCB, or p,p 0-DDE exposure levels as
there were no differences in exposure levels between the
sons who participated in the physical examination, those
who only filled in internet-based questionnaires, and
those who did not participate in the follow-up study
(Table 6). In addition, sons were unaware of their
mothers’ serum POP levels during pregnancy. Hence,
we do not believe that selection bias is a major concern.
Because of the long half-lives of POPs in the human
body, one blood sample measurement in pregnancy
week 30 is considered a satisfactory proxy for fetal
exposure during pregnancy.
A median lipid-adjusted p,p 0-DDE level of 288 ng/g
lipid as measured in serum samples from pregnancy
week 30 in 1988–1989 in the current study is
comparable with p,p 0-DDE levels measured in male
partners of infertility couples in USA in 2000–2001
(275 ng/g lipid) (Hauser et al. 2003), and considerably
higher compared with Scandinavian levels measured in
Northern and Southern Norway in 2001 (66–81 ng/g
lipid; Haugen et al. 2011). The median PCB-153 lipid-
adjusted concentration was 165 ng/g lipid in the current
study, which is somewhat higher than American and
Scandinavian background levels in the 2000s (44–68 ng/g
lipid; Hauser et al. 2003, Richthoff et al. 2003, Haugen
et al. 2011). Thus, our findings are potentially relevant
to contemporary generations.
Despite indications from previous studies of associ-
ations between POP levels in adult life and male
reproductive health, the present results do not suggest
long-term effects of in utero exposure to PCBs or p,p 0-
DDE alone on semen quality measures or reproductive
hormone levels; however it cannot be excluded that
exposure to PCBs and p,p 0-DDE in combination with
other endocrine-modulating compounds may have
adverse effects on the male reproductive system.Supplementary data
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